Journal ArticleOPEN ACCESS

Rituximab-Induced Remission in Epstein−Barr Virus−Associated Glomerulonephritis

Kidney International Reports (2020) 5(11) 2109-2113
DOI: 10.1016/j.ekir.2020.08.027
1Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Cite

CITATION STYLE

APA

Alabdaljabar, M. S., Al-hussain, T. O., Akhtar, M., Conca, W., & Hussein, M. H. (2020). Rituximab-Induced Remission in Epstein−Barr Virus−Associated Glomerulonephritis. Kidney International Reports, 5(11), 2109–2113. https://doi.org/10.1016/j.ekir.2020.08.027

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free